Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
about
Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasisRole of tumor associated macrophages in tumor angiogenesis and lymphangiogenesisThe role of the lymphatic system in endometriosis: a comprehensive review of the literatureObesity and colorectal cancer: molecular features of adipose tissueMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesisInsulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survivalTumour vascularization: sprouting angiogenesis and beyondElevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer.Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulationLymphangiogenesis and lymphatic metastasis in breast cancer.The lymphatic system in health and disease.Targeting lymphatic vessel functions through tyrosine kinases.Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.A role for all-trans-retinoic acid in the early steps of lymphatic vasculature development.The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor.Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicityIGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment.No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal CancerAn overview of lymphatic vessels and their emerging role in cardiovascular diseaseExperimental models to study lymphatic and blood vascular metastasis.Lymphangiogenesis and hemangiogenesis: potential targets for therapyTransforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid.Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling.Lymphatics and lymphangiogenesis in the eye.Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancerMacrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancerCollaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.Tube-like structures with co-expression of D2-40 and CD34: newly formed vasculatures?Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.Relationship between angiogenesis and lymphangiogenesis in recurrent pterygium.RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma.Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study.First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.Hypoxic conditioned medium from mesenchymal stem cells promotes lymphangiogenesis by regulation of mitochondrial-related proteinsGrowth hormone promotes lymphangiogenesis.
P2860
Q24298455-987D5FD0-E148-45C2-AB69-CDD0704D4965Q26865533-0682CDA4-D7BD-4F21-81A8-F6C4A417327AQ27027943-506A77B7-EB77-4D76-A555-D81EEAAB54BBQ28079556-E9CA05DA-55DF-412A-8D6E-B96922F8F683Q30278005-3CB49625-245E-4C5D-A437-52051187F3C5Q33518470-A8BDC885-2D53-4CA6-AD8B-7FA2399FC8BDQ33533645-B780AF23-5660-497F-B7DB-0C332145362CQ33556162-4BDB1DFA-B1F8-4EFB-A891-EF7DA1216230Q33575116-37C6EB71-1D64-4C3B-B746-336ED42AF50DQ33818935-B16F2E76-7C80-4A1A-A7CF-4004A72A705EQ33940058-6C695724-BF58-406A-9F2B-3602DAFFC105Q34015299-3FA59CF3-B815-4AD4-BC8D-E218F582B0DBQ34078275-0BCC5788-BFE2-4EA2-B974-00AB96C1FBB6Q34199527-650305D6-5E6F-4B84-8D79-A88117129A9BQ34382211-3828A55A-4FD8-46F1-B0A2-BB9B068DCCEDQ34439011-F67D0193-4766-4E48-BCCF-F7A902D01A40Q34651968-40601DE3-D87E-451A-B58A-6664BC60D978Q35165700-54E8EF62-BED3-443E-AF4F-5365617830F4Q35340995-A79FDC4D-8F2B-4141-8989-15D58B3A0D96Q35366220-8A136694-5A68-4E0B-BDFC-DB86E8D9D586Q35446777-56A1D4D8-909F-4FEF-AB28-E6E28C7DD98BQ35575870-BAD75166-5B52-44E1-AF18-297778943DA1Q35628188-0FBF5D31-6AA7-4C6C-B172-D41D4148EB9AQ35691047-6328A633-A28E-4D80-8DEC-C3A6F88F0D7FQ35857107-E4C76CC8-B52D-45B8-9B6F-8A6B01993081Q35864976-46B8B1F7-5E88-4217-8F84-8805794910CEQ35882208-E449FBD4-71CB-4182-9F91-AEF35FC308AAQ35913687-55934681-91EA-4D5C-9D37-0F606472091EQ36198192-09427CE3-CF63-4CE8-9867-514422FE31E1Q36237514-1680650D-4B97-4CA4-9E79-169EF8120238Q36300824-15EBB3DB-673C-4EFD-8213-6AFA2EE20C84Q36339264-34163A6B-05CB-4935-8926-90FFEE893041Q36378151-2DA74A2E-A867-45BB-867C-BF8E606D9DD8Q36393036-F2143FAE-5FCE-4938-BD54-58C79A8EDC6EQ36490417-E6AAADB9-A1EB-4E49-8B67-E33A722C60E9Q36544139-78F486AB-6B31-4F94-B6A6-0DB9C8E031D3Q36574123-770FD650-C1B8-40FB-B094-447B4EDF572EQ36612618-4BCB635B-FD33-4FF8-B63F-0B7293E8D1A4Q36678992-199EBA09-5479-489C-B5AF-3C71D45AC135Q36778298-9616CE55-3C99-494F-8933-9FDBB1C25564
P2860
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@ast
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@en
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@nl
type
label
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@ast
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@en
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@nl
prefLabel
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@ast
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@en
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@nl
P2093
P2860
P356
P1476
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
@en
P2093
Anker Jon Hansen
David Jackson
L Johan Nissen
Louise A Johnson
Meit Björndahl
Renhai Cao
Steve Clasper
Zhongjun Zhou
P2860
P304
15593-15598
P356
10.1073/PNAS.0507865102
P407
P577
2005-10-17T00:00:00Z